Mar­ket­ingRx roundup: Su­per Bowl scores last minute ad from di­ag­nos­tic; BBC spot­lights As­traZeneca vac­cine

4 years ago
Pharma
Marketing

From ‘func­tion­al’ to emo­tion­al, Am­gen’s mar­ket­ing for can­cer bone med Xge­va shifts to pa­tients’ sto­ries

4 years ago
Pharma
Marketing

Biofron­tera will yank shares from Nas­daq; In­tel­lia and ONK col­lab­o­rate on can­cer can­di­dates

4 years ago
News Briefing

FDA hits Leg­end Biotech with clin­i­cal hold on CAR-T just days ahead of BC­MA de­ci­sion

4 years ago
FDA+

Re­veal­ing heavy loss­es in new SEC fil­ing, video game ther­a­peu­tic mak­er Ak­ili de­tails an un­cer­tain fi­nan­cial fu­ture

4 years ago
Deals

FDA keeps clin­i­cal hold in place on Lari­mar's lead drug with job cuts like­ly on the hori­zon

4 years ago
FDA+

Cy­to­ki­net­ic­s' lat­est PhI­II study of ome­cam­tiv flops — kick­ing out an­oth­er leg from un­der the mar­ket case it was ...

4 years ago
R&D

AI start­up grabs $60M, un­veils plat­form aimed at drug dis­cov­ery's 'da­ta prob­lem'

4 years ago
Financing
Startups

In putting to­geth­er a $236M Se­ries D, one biotech spurns Nas­daq and sig­nals the dim­ming al­lure of IPOs

4 years ago
Financing

In a cliffhang­er, Rob Califf clears first hur­dle on path to Sen­ate con­fir­ma­tion as next FDA com­mis­sion­er

4 years ago
FDA+

Am­gen comes in sec­ond with its lat­est batch of KRAS da­ta, but its ri­val is still hav­ing prob­lems catch­ing up

4 years ago
R&D

Roche-backed biotech re­fu­els with $40M to steer neu­ro­mus­cu­lar can­di­date to­ward late-stage tri­als

4 years ago
Financing

Scoop: Saman­tha Truex de­parts At­las to head $200M Or­biMed-backed im­munol­o­gy start­up

4 years ago
People
Startups

Mo­bile app de­vel­op­er adds dis­ease-spe­cif­ic mod­ules for pa­tients – and phar­ma part­ners

4 years ago
Pharma
Marketing

GSK joins a crowd of phar­ma com­pa­nies re­strict­ing sales un­der fed­er­al pro­gram

4 years ago
Pharma

J&J de­fends talc bank­rupt­cy gam­bit as plain­tiffs mass in le­gal show­down

4 years ago
Pharma

Look­ing for a quick di­ag­no­sis of your symp­toms? This biotech is build­ing an app for that

4 years ago
Financing
Diagnostics

J&J’s Janssen suits up again for prostate can­cer aware­ness at NY Fash­ion Week and Blue Jack­et show

4 years ago
Pharma
Marketing

North Amer­i­can CD­MO mar­ket poised for a boom to $8.65B by 2026 — re­port

4 years ago
Pharma
Manufacturing

No­var­tis is chop­ping 400 jobs in In­dia af­ter strik­ing new dis­tri­b­u­tion pact

4 years ago
People
Pharma

Bavar­i­an Nordic lands break­through des­ig­na­tion for RSV vac­cine; Ucel­lo clos­es Se­ries A to ad­vance CAR-T ther­a­pies

4 years ago
R&D
News Briefing

Nick Leschly beefs up his C-suite at 2sev­en­ty, hir­ing Bris­tol My­ers alum to lead clin­i­cal push for next-gen CAR-Ts

4 years ago
People

Covid-19 roundup: De­spite treat­ment short­ages, some US phar­ma­cies re­port pile-ups of Mer­ck­'s an­tivi­ral

4 years ago
Coronavirus

Roivant re­veals its newest 'vant,' try­ing to re­boot an Ei­sai blood can­cer pro­gram and out­flank Mer­ck, Bris­tol My­ers

4 years ago
Startups
Pharma
First page Previous page 574575576577578579580 Next page Last page
A service from the Financial Times